Real-time enrollment status for this high-risk localized prostate cancer clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 11:57 PM UTC
| NCT Number | NCT07550517 |
| Recruiting Status | Recruiting |
| Condition | High-Risk Localized Prostate Cancer |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Last Updated on CT.gov | September 22, 2026 (4 weeks ago) |
As of October 21, 2026: Clinical trial NCT07550517 is currently recruiting participants. This phase2 study for high-risk localized prostate cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07550517 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07550517 was last updated 4 weeks ago (September 22, 2026). HelloStudys verifies this status automatically.